BioCentury | Sep 29, 2020
Management Tracks
Garijo picked to succeed Oschmann at Merck KGaA; plus BioShin, Abeona, Rubius, Nimbus, Vizgen
...NYSE:BHVN) announced a series A round and the two top executives of its Asia-Pacific subsidiary, BioShin Ltd....
...tech (see “Arch Backs Vizgen’s RNA Imaging Platform”). Jeff Cranmer Merck KGaA Biohaven Pharmaceutical Holding Co. Ltd. Abeona Rubius Therapeutics Nimbus Therapeutics Vizgen BioShin BioShin Ltd....
...tech (see “Arch Backs Vizgen’s RNA Imaging Platform”). Jeff Cranmer Merck KGaA Biohaven Pharmaceutical Holding Co. Ltd. Abeona Rubius Therapeutics Nimbus Therapeutics Vizgen BioShin BioShin Ltd....
